1 Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France. birgit.geoerger@gustaveroussy.fr.
2 Gustave Roussy Cancer Campus, INSERM U1015, Université Paris-Saclay, Villejuif, France. birgit.geoerger@gustaveroussy.fr.
3 Gustave Roussy Cancer Campus, Biostatistics and Epidemiology Unit, INSERM U1018, CESP, Université Paris-Saclay, UVSQ, Villejuif, France.
4 Institut Curie, INSERM U900 STAMPM, UVSQ, St. Cloud, France.
5 Hospital Niño Jesús, Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Madrid, Spain.
6 Princess Máxima Center for Pediatric Oncology, Utrecht, and Erasmus MC, Rotterdam, the Netherlands.
7 Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
8 Royal Marsden Hospital & The Institute of Cancer Research, Paediatric and Adolescent Oncology Drug Development Unit, London, UK.
9 Hôpital de la Timone, Department of Pediatric Oncology, AP-HM; UMR INSERM 1068, CNRS UMR 7258, Aix Marseille Université U105, Marseille Cancer Research Center (CRCM); Metronomics Global Health Initiative, Marseille, France.
10 Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France.
11 Centre Hospitalier Universitaire Pellegrin-Hôpital des Enfants, Bordeaux, France.
12 Fondazione IRCCS Istituto Nazionale dei Tumori, Pediatric Oncology Unit, Milan, Italy.
13 Rigshospitalet, Department of Paediatrics and Adolescent Medicine, Copenhagen, Denmark.
14 Gustave Roussy Cancer Campus, Clinical Research Direction, Université Paris-Saclay, Villejuif, France.
15 INSERM U830 RTOP (Recherche Translationelle en Oncologie Pédiatrique) and SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), PSL Research University, Institut Curie, Paris, France.